Meridian Medical Technologies^®, Inc., a wholly owned subsidiary of King Pharmaceuticals^®, Inc., has been manufacturing auto-injectors for emergency drug delivery for more than 50 years and has provided more than 185 million to the world market. Meridian's products include: the DuoDote^TM Auto-Injector, the latest advancement in chemical nerve agent antidote technology, a single, pre-filled, dual-chambered auto-injector containing atropine and pralidoxime chloride; the AtroPen^® Auto-Injector (atropine injection); the Pralidoxime Chloride Auto-Injector (pralidoxime chloride injection); the Diazepam Auto-Injector (diazepam injection); and the Morphine Auto-Injector (morphine injection). http://www.duodote.com